FMP
Pasithea Therapeutics Corp.
KTTA
NASDAQ
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
2.63 USD
-0.04 (-1.52%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Tiago Reis Marques M.D., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.pasithea.comexchange
NASDAQ
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
CIK
0001841330
ISIN
US70261F2020
CUSIP
70261F103
Address
1111 Lincoln Road
Phone
702 514 4174
Country
US
Employee
8
IPO Date
Sep 15, 2021
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
KTTA Financial Summary
CIK
0001841330
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
70261F103
ISIN
US70261F2020
Country
US
Price
2.63
Beta
0.82
Volume Avg.
962.6k
Market Cap
3.33M
Shares
-
52-Week
2.37-9.4
DCF
13.25
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.18
P/B
-
Website
https://www.pasithea.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest KTTA News
It looks like there's no news available.
